Daisuke Danno1, Noboru Imai2, Shigekazu Kitamura3

  • 1Headache Center, Department of Neurology, Tominaga Hospital, 1-4-48 Minatomachi, Naniwa Ward, Osaka, Japan. daisukedanno@yahoo.co.jp.

Scientific reports
|September 18, 2024
PubMed
概括

在一项现实研究中,Galcanezumab有效地降低了偏头痛患者的中央敏感性,通过中央敏感性清单 (CSI) 和Allodynia症状检查清单 (ASC-12) 进行测量.